Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED)

v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2018 256,123,515      
Beginning balance, value at Dec. 31, 2018 $ 256,123 $ 111,429,877 $ (113,168,000) $ (1,482,000)
Common stock issued on exercise of warrants and options, shares 4,039,690      
Common stock issued on exercise of warrants and options, value $ 4,040 287,960 292,000
Common stock issued on conversion of notes payable, shares 42,271,760      
Fair value of warrants and beneficial conversion feature of issued convertible notes 1,350,000 1,350,000
Fair value of options and warrants issued as compensation 275,000 275,000
Common stock issued for services, shares 250,000      
Common stock issued for services, value $ 250 67,750 68,000
Net loss (4,728,000) (4,728,000)
Ending balance, shares at Sep. 30, 2019 302,684,965      
Ending balance, value at Sep. 30, 2019 $ 302,685 115,722,315 (117,896,000) (1,871,000)
Beginning balance, shares at Jun. 30, 2019 298,457,191      
Beginning balance, value at Jun. 30, 2019 $ 298,456 115,085,544 (116,908,000) (1,524,000)
Common stock issued on exercise of warrants and options, shares 362,500      
Common stock issued on exercise of warrants and options, value $ 363 18,637 19,000
Common stock issued on conversion of notes payable, shares 3,865,274      
Common stock issued on conversion of notes payable, value $ 3,866 305,134   309,000
Fair value of warrants and beneficial conversion feature of issued convertible notes 232,000 232,000
Fair value of options and warrants issued as compensation 81,000 81,000
Net loss (988,000) (988,000)
Ending balance, shares at Sep. 30, 2019 302,684,965      
Ending balance, value at Sep. 30, 2019 $ 302,685 115,722,315 (117,896,000) (1,871,000)
Beginning balance, shares at Dec. 31, 2019 310,111,536      
Beginning balance, value at Dec. 31, 2019 $ 310,111 116,209,889 (118,789,000) (2,269,000)
Common stock issued on exercise of warrants and options, shares 1,215,000      
Common stock issued on exercise of warrants and options, value $ 1,215 59,785 61,000
Common stock issued on conversion of notes payable, shares 8,094,707      
Common stock issued on conversion of notes payable, value $ 8,096 366,904   375,000
Fair value of warrants and beneficial conversion feature of issued convertible notes 212,000 212,000
Fair value of options and warrants issued as compensation 296,000 296,000
Common stock issued for cash in private sale of securities, shares 1,666,667      
Common stock issued for cash in private sale of securities, value $ 1,667 23,333 25,000
Net loss (2,043,000) (2,043,000)
Ending balance, shares at Sep. 30, 2020 321,087,910      
Ending balance, value at Sep. 30, 2020 $ 321,089 117,167,911 (120,832,000) (3,343,000)
Beginning balance, shares at Jun. 30, 2020 319,421,243      
Beginning balance, value at Jun. 30, 2020 $ 319,422 117,061,578 (120,396,000) (3,015,000)
Fair value of options and warrants issued as compensation   83,000   83,000
Common stock issued for cash in private sale of securities, shares 1,666,667      
Common stock issued for cash in private sale of securities, value $ 1,667 23,333   25,000
Net loss     (436,000) (436,000)
Ending balance, shares at Sep. 30, 2020 321,087,910      
Ending balance, value at Sep. 30, 2020 $ 321,089 $ 117,167,911 $ (120,832,000) $ (3,343,000)